Compounds > pristane
Page last updated: 2024-08-21

pristane and Disease Exacerbation

pristane has been researched along with Disease Exacerbation in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's4 (44.44)24.3611
2020's3 (33.33)2.80

Authors

AuthorsStudies
Chatthanathon, P; Hiengrach, P; Issara-Amphorn, J; Jaroonwitchawan, T; Leelahavanichkul, A; Palaga, T; Pisitkun, P; Somboonna, N; Surawut, S; Thim-Uam, A; Wilantho, A1
Abdelhamid, L; Cabana-Puig, X; Cecere, TE; Lee, J; LeRoith, T; Li, S; Li, Y; Luo, XM; Reilly, CM; Ross, AC; Sun, S; Swartwout, B; Wang, H; Werre, SR1
Feng, J; Fu, W; Han, P; Hou, J; Li, J; Li, Z; Liu, C; Liu, F; Liu, Y; Ma, Y; Mu, R; Niu, J; Xu, D; Yang, G1
Bandur, T; Blüml, S; Leiss, H; Niederreiter, B; Schwarzecker, B; Smolen, JS; Steiner, G; Stummvoll, GH; Ulrich, W1
Chen, YC; Du, GH; Fang, JS; He, YY; Lin, YH; Wu, P; Yan, Y; Yang, SH; Zhang, HF1
Allaire, N; Bajko, J; Browning, JL; Chou, WC; Czerkowicz, JM; Dunstan, RW; Fu, K; Gardet, A; Kerns, HM; Lafyatis, R; Legault, HM; Lukashev, M; Rabah, D; Ranger, AM; Reynolds, TL; Ryan, S; Velez, DB; Viney, JL1
Brenner, M; Gulko, PS; Laragione, T; Mello, A; Remmers, EF; Shah, A; Wilder, RL1
Bornkamm, GW; Felix, K; Janz, S; Kelliher, KA1
Francis, JN; Lamont, AG; Thompson, SJ1

Other Studies

9 other study(ies) available for pristane and Disease Exacerbation

ArticleYear
Leaky-gut enhanced lupus progression in the Fc gamma receptor-IIb deficient and pristane-induced mouse models of lupus.
    Scientific reports, 2020, 01-21, Volume: 10, Issue:1

    Topics: Animals; beta-Glucans; Cytokines; Dextran Sulfate; Disease Models, Animal; Disease Progression; Feces; Female; Lupus Erythematosus, Systemic; Mice; Receptors, IgG; Terpenes

2020
Retinoic Acid Exerts Disease Stage-Dependent Effects on Pristane-Induced Lupus.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Animals; Bacterial Translocation; Contraindications, Drug; Dendritic Cells; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Drug Synergism; Dysbiosis; Female; Gastrointestinal Microbiome; Gene Expression Regulation; Glomerulonephritis; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred BALB C; Real-Time Polymerase Chain Reaction; RNA; RNA-Seq; Specific Pathogen-Free Organisms; Spleen; Terpenes; Tretinoin; Vitamin A

2020
A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Amino Acid Sequence; Animals; Antigens, Bacterial; Autoantibodies; Autoantigens; Bacteria; Biofilms; Biomarkers; Disease Models, Animal; Disease Progression; Disease Susceptibility; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Transgenic; Peptides; Terpenes

2021
Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation.
    Lupus, 2013, Volume: 22, Issue:8

    Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoantibodies; Disease Models, Animal; Disease Progression; Female; Granulocytes; Inflammation; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Severity of Illness Index; Species Specificity; Terpenes; Time Factors

2013
Methyl salicylate 2-
    Drug design, development and therapy, 2016, Volume: 10

    Topics: Animals; Autoantibodies; Cytokines; Disease Progression; Female; Glycosides; Inflammation; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Salicylates; Signal Transduction; Terpenes

2016
Pristane-Accelerated Autoimmune Disease in (SWR X NZB) F1 Mice Leads to Prominent Tubulointerstitial Inflammation and Human Lupus Nephritis-Like Fibrosis.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Animals; Autoantibodies; Disease Models, Animal; Disease Progression; DNA-Binding Proteins; Female; Fibrosis; Glomerulonephritis; Humans; Hypergammaglobulinemia; Inflammation; Kidney Tubules; Lupus Nephritis; Membrane Proteins; Mice; Terpenes; Transcription, Genetic; Up-Regulation

2016
Identification of two new arthritis severity loci that regulate levels of autoantibodies, interleukin-1β, and joint damage in pristane- and collagen-induced arthritis.
    Arthritis and rheumatism, 2012, Volume: 64, Issue:5

    Topics: Animals; Animals, Congenic; Arthritis, Experimental; Autoantibodies; Biomarkers; Collagen; Collagen Type II; Disease Progression; Gene Expression; Genetic Markers; Immunosuppressive Agents; Interleukin-1beta; Joints; Metalloproteases; Quantitative Trait Loci; Rats; Rats, Inbred F344; Severity of Illness Index; Species Specificity; Synovial Membrane; Terpenes

2012
Elevated mutant frequencies in lymphoid tissues persist throughout plasmacytoma development in BALB/c.lambdaLIZ mice.
    Cancer research, 1999, Aug-01, Volume: 59, Issue:15

    Topics: Animals; Bacterial Proteins; Carcinogens; Disease Progression; DNA; DNA Mutational Analysis; DNA, Neoplasm; Escherichia coli Proteins; Female; Genes, Reporter; Lac Operon; Lac Repressors; Lymph Nodes; Lymphoid Tissue; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Mutagenesis; Peritoneal Neoplasms; Plasmacytoma; Repressor Proteins; Spleen; Terpenes

1999
The route of administration of an immunodominant peptide derived from heat-shock protein 65 dramatically affects disease outcome in pristane-induced arthritis.
    Immunology, 2000, Volume: 99, Issue:3

    Topics: Animals; Arthritis, Experimental; Bacterial Proteins; Cell Division; Cells, Cultured; Chaperonin 60; Chaperonins; Cytokines; Disease Progression; Epitopes; Immunosuppressive Agents; Immunotherapy; Injections, Intraperitoneal; Instillation, Drug; Interferon-gamma; Interleukin-10; Interleukin-4; Interleukin-5; Mice; Mice, Inbred CBA; T-Lymphocytes; Terpenes

2000